Intravenous Nitroglycerin Infusion: Dosing, Administration, and Safety Guidelines

Maximum Dosing

The American College of Cardiology/American Heart Association (ACC/AHA) recommends a standard maximum intravenous nitroglycerin infusion rate of 200 µg/min for most clinical situations. 1
Doses up to 400 µg/min have been employed in select circumstances with careful monitoring, but 200 µg/min remains the generally accepted ceiling when a higher limit is not explicitly defined. 2
For hypertensive emergencies, the ACC/AHA sets a lower ceiling of 20 µg/min. 3

Using a micro‑drip set (60 drops = 1 mL), a 200 µg/min infusion corresponds to 200 drops/min (≈ 12,000 drops/hour). 1
Using a macro‑drip set (15 drops = 1 mL), the same infusion rate corresponds to 50 drops/min (≈ 3,000 drops/hour). 2

The ACC/AHA advises initiating therapy at 5–20 µg/min and increasing by 5–10 µg/min every 3–5 minutes based on clinical response. 1
The European Society of Cardiology (ESC) recommends starting at 10–20 µg/min with the same incremental steps of 5–10 µg/min every 3–5 minutes. 4
In hypertensive emergencies, begin at 5 µg/min and titrate in 5 µg/min increments every 3–5 minutes to a maximum of 20 µg/min. 3

Nitroglycerin infusion should be avoided when systolic blood pressure is < 90 mmHg or has fallen > 30 mmHg below the patient’s baseline. 3
Continuous arterial blood‑pressure monitoring is essential; placement of an arterial line is recommended for higher‑dose infusions or when baseline pressures are borderline. 4

Tachyphylaxis typically emerges after 24–48 hours of continuous infusion, often necessitating dose escalation. 4
Prolonged infusions at 300–400 µg/min for 2–4 weeks have not been shown to increase methemoglobin levels, although such rates exceed standard maximum recommendations. 2

Recent use of phosphodiesterase‑5 inhibitors (e.g., within 24 hours for short‑acting agents or 48 hours for long‑acting agents) due to the risk of life‑threatening hypotension. 1
Presence of advanced aortic stenosis, which predisposes patients to marked hypotension. 3
Volume‑depleted states, which increase the risk of severe hypotension during infusion. 3

Rapid titration can precipitate excessive hypotension, especially in patients who are volume‑depleted. 4
Headache is a frequent side effect; it usually requires symptomatic treatment but does not mandate discontinuation of therapy. 4
Abrupt discontinuation may cause rebound myocardial ischemia; a gradual taper is recommended when stopping the infusion. 2

The American College of Cardiology recommends starting with 10-20 mcg/min via continuous infusion using non-absorbing tubing 5
Titrate by increasing 5-10 mcg/min every 3-5 minutes based on clinical response, as suggested by the European Heart Journal 6
For hypertensive emergencies, nitroglycerin should be initiated at 5 mcg/min and increased in increments of 5 mcg/min every 3-5 minutes as needed, according to Hypertension 7

The maximum recommended infusion rate is typically 200 mcg/min, as recommended by the Journal of the American College of Cardiology 8
Higher doses up to 400 mcg/min may be used in certain clinical situations with careful monitoring, according to Praxis Medical Insights 5

Maintain systolic blood pressure (SBP) >110 mmHg in previously normotensive patients, as suggested by Praxis Medical Insights 5
In hypertensive patients, do not reduce SBP by more than 25% within the first hour, according to Hypertension 7
Avoid use in patients with SBP <90 mmHg or 30 mmHg below baseline, as recommended by Praxis Medical Insights 5
Continuous BP monitoring is recommended; arterial line placement is advised for higher doses or borderline BP, according to the European Heart Journal 6

Tachyphylaxis (tolerance) typically develops after 24-48 hours of continuous therapy, requiring dose adjustments, as suggested by the Journal of the American College of Cardiology 8
Use with extreme caution in patients with right ventricular infarction due to preload dependency, according to Praxis Medical Insights 5
Avoid in patients with advanced aortic stenosis, as recommended by Hypertension 7

Excessive hypotension can occur with rapid titration, especially in volume-depleted patients, according to the European Heart Journal 6
Headache is a common side effect that may require symptomatic management, as suggested by the European Heart Journal 6